Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dubach

Showing results (491-500 of 492) with videos related to

Pageof 50
Sort By:
You have reached the last page of results.This site can display upto 492 results.
Journal of Cachexia, Sarcopenia and Muscle|October 4, 2011
The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexiaR Dallmann, P Weyermann, C Anklin, et al.
Iscience|January 9, 2023
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan regionMarc Emmenegger, Elena De Cecco, David Lamparter, et al.
Pageof 50

Showing results (491-500 of 492) with videos related to

Sort By:
Pageof 50
You have reached the last page of results.This site can display upto 492 results.
Journal of Cachexia, Sarcopenia and Muscle|October 4, 2011
The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexiaR Dallmann, P Weyermann, C Anklin, et al.
Iscience|January 9, 2023
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan regionMarc Emmenegger, Elena De Cecco, David Lamparter, et al.
Pageof 50